Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Operating Expenses (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Operating Expenses readings, the most recent being $1.5 billion for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 5.71% to $1.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.6 billion, a 0.68% decrease, with the full-year FY2025 number at $5.5 billion, down 1.7% from a year prior.
  • Operating Expenses hit $1.5 billion in Q1 2026 for GE HealthCare Technologies, up from $1.4 billion in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.5 billion in Q4 2024 to a low of $1.2 billion in Q4 2022.
  • Median Operating Expenses over the past 5 years was $1.4 billion (2024), compared with a mean of $1.3 billion.
  • Biggest five-year swings in Operating Expenses: grew 27.01% in 2023 and later fell 4.59% in 2025.
  • GE HealthCare Technologies' Operating Expenses stood at $1.2 billion in 2022, then increased by 27.01% to $1.5 billion in 2023, then grew by 0.48% to $1.5 billion in 2024, then fell by 2.71% to $1.4 billion in 2025, then rose by 1.95% to $1.5 billion in 2026.
  • The last three reported values for Operating Expenses were $1.5 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.3 billion (Q3 2025) per Business Quant data.